Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Neuronetics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 66 | 67 | +1 |
| Shares | 17.7M | 17.5M | −172.3K (−1.0%) |
| Value | $84.2M | $31.5M | −$52.7M (−62.6%) |
New holders (8)
Institutions that held Neuronetics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Essex Investment Management Co LLC | 82,668 | $148.8K | 0.03% |
| Gsa Capital Partners LLP | 47,805 | $86.0K | 0.01% |
| Legato Capital Management LLC | 24,540 | $44.2K | 0.01% |
| Blair William & Co | 10,589 | $19.1K | 0.00% |
| Royal Bank of Canada | 2,843 | $5.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,524 | $4.54K | 0.00% |
| Advisor Group Holdings, Inc. | 838 | $1.51K | 0.00% |
| Simplex Trading, LLC | 143 | $0 | 0.00% |
Sold out (7)
Institutions that held Neuronetics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Thompson Siegel & Walmsley LLC | 88,702 | $422.0K |
| Jump Financial, LLC | 43,754 | $208.3K |
| Y-Intercept (Hong Kong) Ltd | 24,362 | $116.0K |
| SG Americas Securities, LLC | 13,048 | $62.0K |
| Goldman Sachs Group Inc | 11,846 | $56.4K |
| XTX Topco Ltd | 11,846 | $56.4K |
| Wells Fargo & Company | 10,215 | $48.6K |